In this article, We will analyze KILITCH DRUG to build a profitable portfolio, and also pivot technical analysis..
52 WEEK HIGH AND 52 WEEK LOW
KILITCH DRUG 52 week high is 228.05 and 52 week low is 78.25 .
EPS
KILITCH DRUG earning per share is 1.86
VWAP
VWAP level is 173.21 based on the closing price. This is on hourly chart
Revenue
The KILITCH DRUG Net Revenue from last quarter is 19.51 crore.
FACE VALUE
The KILITCH DRUG Face value is 10.00.
Market Capital
The KILITCH DRUG Full Market Capital is271.95crore.
INDUSTRY
KILITCH DRUG is listed under Pharmaceuticals industry.
Index
KILITCH DRUG is part of the BIndex Group.
